✦ LIBER ✦

MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR TAG3 OR T1G3 AND/OR CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMISED CUETO GROUP STUDY

✍ Scribed by L. Martinez-Pineiro; R. Hernandez; J.A. Zabala; J.M. Fernandez; J.L. Moyano; E. Solsona; M. Unda

Book ID: 119619236
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 73 KB
Volume: 7
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(08)60905-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1007 Maintenance bacillus Calmette-Gueri

1007 Maintenance bacillus Calmette-Guerin immunotherapy for TaG3 or T1G3 and/or carcinoma in situ transitional cell carcinoma of the bladder: Final results of the randomized CUETO Group Study 98013

✍ Martínez-Piñeiro, L.; Hernández, R.; Portillo, J.A.; Fernández, J.M.; Zabala, J. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 113 KB

MAINTENANCE BACILLUS CALMETTE-GUERIN IMM

MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY

✍ LAMM, DONALD L.; BLUMENSTEIN, BRENT A.; CRISSMAN, JOHN D.; MONTIE, JAMES E.; GOT 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 83 KB

Intravesical Bacillus Calmette-Guerin Th

Intravesical Bacillus Calmette-Guerin Therapy for Stage T1 Grade 3 Transitional Cell Carcinoma of the Bladder: Recurrence, Progression and Survival in a Study of 57 Patients

✍ PEYROMAURE, MICHAEL; GUERIN, FLORENT; AMSELLEM-OUAZANA, DELPHINE; SAIGHI, DJILLA 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 62 KB

Randomized intergroup comparison of baci

Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study

✍ Donald L. Lamm; Brent A. Blumenstein; E. David Crawford; John D. Crissman; Bruce 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 937 KB

PROGNOSTIC FACTORS IN PATIENTS WITH INTE

PROGNOSTIC FACTORS IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE TA T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE EPIRUBICIN OR MAINTENANCE BACILLUS CALMETTE-GUERIN. RESULTS OF EORTC GU GROUP STUDY 30911

✍ R.J. Sylvester; W. Oosterlinck; M.A. Brausi; W.J. Kirkels; F. Calais Da Silva; T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

PROGNOSTIC FACTORS IN PATIENTS WITH INTE

PROGNOSTIC FACTORS IN PATIENTS WITH INTERMEDIATE AND HIGH RISK STAGE Ta T1 PAPILLARY CARCINOMA OF THE BLADDER TREATED WITH MAINTENANCE EPIRUBICIN OR MAINTENANCE BACILLUS CALMETTE-GUERIN. RESULTS OF EORTC GU GROUP STUDY 30911

✍ Sylvester, Richard; Oosterlinck, Willem; Brausi, Maurizio; Kirkels, Wim J; Da Si 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 146 KB